These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 1969897)

  • 1. Dosimetric aspects of exposure of the population to ionizing radiation.
    Broerse JJ; Dennis JA
    Int J Radiat Biol; 1990 Apr; 57(4):633-45. PubMed ID: 1969897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer and non-cancer effects in Japanese atomic bomb survivors.
    Little MP
    J Radiol Prot; 2009 Jun; 29(2A):A43-59. PubMed ID: 19454804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exposure to ionizing radiation and development of bone sarcoma: new insights based on atomic-bomb survivors of Hiroshima and Nagasaki.
    Samartzis D; Nishi N; Hayashi M; Cologne J; Cullings HM; Kodama K; Miles EF; Funamoto S; Suyama A; Soda M; Kasagi F
    J Bone Joint Surg Am; 2011 Jun; 93(11):1008-15. PubMed ID: 21984980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New dosimetry of atomic bomb radiations.
    Fry RJ; Sinclair WK
    Lancet; 1987 Oct; 2(8563):845-8. PubMed ID: 2889042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of neutrons in Hiroshima. Implications for the risk estimates.
    Kellerer AM
    C R Acad Sci III; 1999; 322(2-3):229-37. PubMed ID: 10196677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A parallel analysis of cancer mortality among atomic bomb survivors and patients with ankylosing spondylitis given X-ray therapy.
    Darby SC; Nakashima E; Kato H
    J Natl Cancer Inst; 1985 Jul; 75(1):1-21. PubMed ID: 3859683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutrons at Hiroshima: how their disappearance affected risk estimates.
    Ellett WH
    Radiat Res; 1991 Oct; 128(1 Suppl):S147-52. PubMed ID: 1924742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiation therapy among atomic bomb survivors, Hiroshima and Nagasaki.
    Kato K; Antoku S; Russell WJ; Fujita S; Pinkston JA; Hayabuchi N; Hoshi M; Kodama K
    Radiat Res; 1998 Jun; 149(6):614-24. PubMed ID: 9611100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medical X-ray doses' contributions to the ionizing radiation exposures of atomic-bomb survivors.
    Kato K; Sawada S
    J Radiat Res; 1991 Mar; 32 Suppl():136-53. PubMed ID: 1762099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hiroshima and Nagasaki: new doses, risks, and their implications.
    Schull WJ; Shimizu Y; Kato H
    Health Phys; 1990 Jul; 59(1):69-75. PubMed ID: 2358361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies of cancer and radiation dose among atomic bomb survivors. The example of breast cancer.
    Land CE
    JAMA; 1995 Aug; 274(5):402-7. PubMed ID: 7616636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer risk estimates from the combined Japanese A-bomb and Hodgkin cohorts for doses relevant to radiotherapy.
    Schneider U; Walsh L
    Radiat Environ Biophys; 2008 Apr; 47(2):253-63. PubMed ID: 18157543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ionizing radiation exposure and the development of soft-tissue sarcomas in atomic-bomb survivors.
    Samartzis D; Nishi N; Cologne J; Funamoto S; Hayashi M; Kodama K; Miles EF; Suyama A; Soda M; Kasagi F
    J Bone Joint Surg Am; 2013 Feb; 95(3):222-9. PubMed ID: 23389785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malignant neoplasms among atomic bomb survivors following radiation therapy.
    Pinkston JA; Antoku S; Russell WJ
    Acta Radiol Oncol; 1981; 20(4):267-71. PubMed ID: 6277156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of death among children of atomic bomb survivors after 62 years of follow-up: a cohort study.
    Grant EJ; Furukawa K; Sakata R; Sugiyama H; Sadakane A; Takahashi I; Utada M; Shimizu Y; Ozasa K
    Lancet Oncol; 2015 Oct; 16(13):1316-23. PubMed ID: 26384241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the risks of cancer incidence and mortality following radiation therapy for benign and malignant disease with the cancer risks observed in the Japanese A-bomb survivors.
    Little MP
    Int J Radiat Biol; 2001 Apr; 77(4):431-64. PubMed ID: 11304437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer risk among atomic bomb survivors. The RERF Life Span Study. Radiation Effects Research Foundation.
    Shimizu Y; Schull WJ; Kato H
    JAMA; 1990 Aug; 264(5):601-4. PubMed ID: 2366300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leukaemia in Nagasaki atomic bomb survivors from 1945 through 1959.
    TOMONAGA M
    Bull World Health Organ; 1962; 26(5):619-31. PubMed ID: 13921808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Workshop Report on Atomic Bomb Dosimetry--Review of Dose Related Factors for the Evaluation of Exposures to Residual Radiation at Hiroshima and Nagasaki.
    Kerr GD; Egbert SD; Al-Nabulsi I; Bailiff IK; Beck HL; Belukha IG; Cockayne JE; Cullings HM; Eckerman KF; Granovskaya E; Grant EJ; Hoshi M; Kaul DC; Kryuchkov V; Mannis D; Ohtaki M; Otani K; Shinkarev S; Simon SL; Spriggs GD; Stepanenko VF; Stricklin D; Weiss JF; Weitz RL; Woda C; Worthington PR; Yamamoto K; Young RW
    Health Phys; 2015 Dec; 109(6):582-600. PubMed ID: 26509626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies of the mortality of A-bomb survivors. 9. Mortality, 1950-1985: Part 1. Comparison of risk coefficients for site-specific cancer mortality based on the DS86 and T65DR shielded kerma and organ doses.
    Shimizu Y; Kato H; Schull WJ; Preston DL; Fujita S; Pierce DA
    Radiat Res; 1989 Jun; 118(3):502-24. PubMed ID: 2727272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.